Iraq, Egypt set to purchase COVID-19 vaccine

Galss bottles with Covid-19 vaccine are seen as elderly people and workers receive a Pfizer-BioNTech coronavirus (COVID-19) vaccine at Mishan Efal Nursing Home, in Tel Aviv on 23 December 2020 [Nir Keidar/Anadolu Agency]

The health authorities in Iraq and Egypt announced on Thursday the purchase of millions of doses of the coronavirus vaccine, from AstraZeneca, Pfizer-BioNTech and China’s Sinopharm, reports Anadolu Agency.

In a news conference, Iraqi Health Minister Hassan al-Tamimi said that Iraq purchased 17.5 million doses of the coronavirus vaccine, a quantity that covers around 20% of the Iraqi population, estimated as 37 million, according to recent official figures.

Al-Tamimi added that “16 million doses are purchased from the British AstraZeneca company and 1.5 million doses from the US Pfizer company.”

In Egypt, the Egyptian Finance Minister Mohammad Maait said in a press conference on Thursday evening that his country will purchase 50 million doses of the coronavirus vaccine.

Maait said that Egypt reached a deal with AstraZeneca for the purchase of 30 million doses and the Chinese Sinopharm group for 20 million doses.

Iraq has registered so far 588,803 infections including 21,744 deaths and 527,341 recoveries. Egypt has confirmed 128,993 infections including 7,260 deaths and 108,474 recoveries.

Read: Europe MPs call for ending siege on Gaza, allowing COVID relief in

Unless otherwise stated in the article above, this work by Middle East Monitor is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. If the image(s) bear our credit, this license also applies to them. What does that mean? For other permissions, please contact us.